Serax and Hallucinations - a phase IV clinical study of FDA data

Summary:

Hallucinations is reported as a side effect among people who take Serax (oxazepam), especially for people who are male, 20-29 old, also take Gilenya, and have Relapsing-remitting multiple sclerosis.

The phase IV clinical study analyzes which people have Hallucinations when taking Serax. It is created by eHealthMe based on reports of 1,473 people who have side effects when taking Serax from the FDA, and is updated regularly.

What is Serax?

Serax has active ingredients of oxazepam. It is often used in stress and anxiety. eHealthMe is studying from 1,542 Serax users. Check the latest studies of Serax.

What is Hallucinations?

Hallucinations (sensations that appear real but are created by your mind) is found to be associated with 1,896 drugs and 2,724 conditions by eHealthMe. Check the latest studies of Hallucinations.

On Jul, 13, 2026

1,473 people reported to have side effects when taking Serax.
Among them, 16 people (1.09%) have Hallucinations.

Among these 16 people:

What is the gender of people who have Hallucinations when taking Serax? *

female: 25 %
male: 75 %

What is the age of people who have Hallucinations when taking Serax? *

What are other drugs people take besides Serax? *

What are other side effects people have besides Hallucinations? *

Paranoia (psychotic disorder characterized by delusions of persecution with or without grandeur): 9 people, 56.25%
Rashes (redness): 8 people, 50.00%
Urinary Retention (the inability to completely or partially empty the bladder): 7 people, 43.75%
Aggression: 7 people, 43.75%
Hypoaesthesia (reduced sense of touch or sensation): 6 people, 37.50%
Depressed Mood: 5 people, 31.25%
Acne (skin problems that cause pimples): 5 people, 31.25%
Mood Swings (an extreme or rapid change in mood): 5 people, 31.25%
Memory Loss: 4 people, 25.00%
Agitation (state of anxiety or nervous excitement): 3 people, 18.75%

What are the existing conditions these people have? *

Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 7 people, 43.75%
Pain: 2 people, 12.50%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 1 person, 6.25%
Quit Smoking: 1 person, 6.25%
Progressive Relapsing Multiple Sclerosis (chronic autoimmune disease of the central nervous system in which gradual destruction of myelin occurs in patches throughout the brain or spinal cord or both): 1 person, 6.25%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Serax and have Hallucinations?

- Check whether Hallucinations is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Serax:

Serax (1,542 reports)

Hallucinations treatments and more:

Hallucinations (98,683 reports)

Browse all side effects of Serax:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hallucinations:

Hallucinations (1,896 drugs)

Browse all the conditions that are associated with Hallucinations:

Hallucinations (2,724 conditions)

Related publications that referenced our studies

Ezeji GC, Inoue T, Bahtiyar G, Sacerdote A, "Hallucinations associated with miglitol use in a patient with chronic kidney disease and hypothyroidism", BMJ case reports, 2015 Feb .
Boschee T, DO PGY II, "Acute Hallucinations: Where Did That Come From?", , 2007 Jan .
Ezeji GC, Inoue T, Bahtiyar G, Sacerdote A, "Hallucinations associated with miglitol use in a patient with chronic kidney disease and hypothyroidism", BMJ case reports, 2015 Feb .
Boschee T, DO PGY II, "Acute Hallucinations: Where Did That Come From?", , 2007 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on oxazepam (the active ingredients of Serax) and Serax (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.